Elicio Therapeutics's total assets for Q3 2025 were $28.28M, a decrease of -4.21% from the previous quarter. ELTX total liabilities were $24.47M for the fiscal quarter, a -11.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.